Taro Pharmaceutical Indus Q3 2024 GAAP EPS $0.54 Beats $0.30 Estimate
Taro Pharmaceutical Indus Q3 2024 GAAP EPS $0.54 Beats $0.30 Estimate
太郎制药工业公司2024年第三季度GAAP每股收益0.54美元，超过预期的0.30美元
Taro Pharmaceutical Indus (NYSE:TARO) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.30 by 80 percent. The company reported quarterly sales of $157.10 million which beat the analyst consensus estimate of $154.91 million by 1.42 percent. This is a 12.86 percent increase over sales of $139.20 million the same period last year.
太郎制药工业公司（纽约证券交易所代码：TARO）公布的季度收益为每股0.54美元，比分析师普遍预期的0.30美元高出80％。该公司公布的季度销售额为1.571亿美元，比分析师普遍预期的1.5491亿美元高出1.42％。这比去年同期的1.3920亿美元销售额增长了12.86％。